Find your path to Philippe
22 people in our graph share verified history with Philippe — schools, employers, funds. One of them is your warm intro.
About
Philippe Dro is trained in industrial pharmacy and finance and has worked across the European biotech and medtech sectors. His recent roles include Board member and CBO of Themis Biosciences (acquired by Merck & Co) and CEO and Supervisory Board member of GlycoVaxyn AG (acquired by GSK); earlier he served as CEO and Chairman of Endoart S.A. (acquired by Allergan) and was part of the founding team at Axovan (acquired by Actelion). His earlier pharmaceutical career included management positions at Novartis, SkyePharma, and Antares Pharma.
Contact· self-published, not guessed
Invests in
BiotechMedical Devices
Investments
Board seats
Luciole Medical AGScenic Biotech BV
Investor
Sources: the firm's website · curated public sources.
Colleagues at Adjuvant Capital
Frequently asked questions
- Who is Philippe Dro?
- Philippe Dro is trained in industrial pharmacy and finance and has worked across the European biotech and medtech sectors. His recent roles include Board member and CBO of Themis Biosciences (acquired by Merck & Co) and CEO and Supervisory Board member of GlycoVaxyn AG (acquired by GSK); earlier he served as CEO and Chairman of Endoart S.A. (acquired by Allergan) and was part of the founding team at Axovan (acquired by Actelion). His earlier pharmaceutical career included management positions at Novartis, SkyePharma, and Antares Pharma.
- Where does Philippe Dro work?
- Philippe Dro is Partner at Adjuvant Capital.
- What does Philippe Dro invest in?
- Philippe Dro invests in Biotech, Medical Devices.
- What check size does Philippe Dro write?
- Philippe Dro typically writes checks of $100K – $5M.
- What boards does Philippe Dro sit on?
- Philippe Dro holds tracked board seats at Luciole Medical AG, Scenic Biotech BV.
- What companies has Philippe Dro invested in?
- Investments tracked here include Memo Therapeutics.